Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

Clinical trial NCT06763328 · RECRUITING

Trial details

NCT number: NCT06763328
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Invasive Breast Carcinoma

Start date: 2024-12-16
Primary completion: 2029-06-16
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.